Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00917059 · ClinicalTrials.gov registry record · Phase 4
Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
A Phase 4 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 4
- Development phase
- 172
- Enrollment target
NCT00917059: Completed Phase 4 study, sponsored by University of California, Los Angeles.
NCT00917059 is a Phase 4 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 172 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00917059, a Phase 4 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 172 participants
- Enrollment target
Study Summary
This study will examine whether measures of brain electrical signals taken after a week of antidepressant medication treatment can predict whether a full treatment regimen will be effective.
Interventions
- DRUG Escitalopram
- DRUG Bupropion XL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 4 |
What the finished NCT00917059 record still lists
NCT00917059 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT00917059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00917059 about?
NCT00917059 is a clinical study titled "Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)". This study will examine whether measures of brain electrical signals taken after a week of antidepressant medication treatment can predict whether a full treatment regimen will be effective.
What is the current status of trial NCT00917059?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 172 participants. The study started on 2009-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00917059?
The interventions under investigation include: Escitalopram (DRUG), Bupropion XL (DRUG).
Who is sponsoring clinical trial NCT00917059?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00917059's enrollment target sits among peer trials
172 481st of 2000 higher than 1,517 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia